Navigation Links
UCSF, Sanofi collaborate to find new diabetes cures
Date:1/10/2012

The University of California, San Francisco (UCSF) has signed an alliance with international pharmaceutical company Sanofi (EURONEXT: SAN and NYSE: SNY) to share expertise in diabetes research and identify drug targets that could lead to new therapies for both type 1 and type 2 diabetes.

The $3.1 million collaboration will bring together scientists in three UCSF labs with deep understanding of the biology of beta cells insulin-producing cells that are destroyed in type 1 diabetes and often produce too little insulin in type 2 with Sanofi researchers who are experienced in developing potential drug candidates into actual therapies.

"This is a true partnership between scientists with very different strengths," said Matthias Hebrok, PhD, director of the UCSF Diabetes Center. "UCSF is known for its deep understanding of the underlying biology of diabetes, while Sanofi has great expertise in screening compounds, identifying which molecules have potential, and moving them along to develop a new drug. Such an endeavor is almost impossible to accomplish in a single academic laboratory. Thus, both partners profit from the expertise of the other group."

The alliance is the University's third collaboration with Sanofi, alongside brain trauma and oncology research launched last year, since the two signed a master agreement in January 2011 to work together in translating academic science into potential new therapies. Master agreements lay out the fundamental terms of research collaborations, align with the University's academic mission including broad publication rights, and form part of a core strategy for the UCSF Office of Innovation, Technology and Alliances to expedite that "bench-to-bedside" research.

Partnershp Combines Expertise on Both Sides

This also is the first collaboration of its kind for the UCSF Diabetes Center, extending beyond simpler, funded-research agreements to create a two-way partnership in which s
'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. UCSF, GE Healthcare team up on pioneering cord blood project
2. Dana-Farber and sanofi-aventis establish cancer research alliance
3. Sanofi-aventis enters into a research and development collaboration with UCSF
4. Institut Pasteur Korea and Sanofi open a new research collaboration to combat HBV
5. Entrust, 3M Collaborate to Provide End-to-End Secure ePassport Solution
6. Animal trackers collaborate on new Google Earth for oceans
7. Springer and Senckenberg society to collaborate on life sciences and geosciences journals
8. UTSA, Health Science Center collaborate with Merck & Co. to develop chlamydia vaccine
9. Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science
10. Springer to collaborate with the Human Genome Organization
11. Rutgers to collaborate in $3.4 million effort to improve prostate cancer identification using MRI
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCSF, Sanofi collaborate to find new diabetes cures
(Date:8/20/2014)... grows to about 4,000 members, it triggers an important ... a special type of comb used for rearing male ... Department of Neurobiology and Behaviour at Cornell University, led ... of honeybee colonies. The results are published in Springer,s ... , Reproduction isn,t always a honeybee colony,s top ...
(Date:8/20/2014)... 20, 2014  The second annual Biometrics UnPlugged ... Tampa, Florida on September 15, ... Rahman, Director, Technology and Strategy at Samsung, and Philippe ... theme of this year,s event is Mobility at ... "Biometrics UnPlugged: Mobility at the Crossroads of ...
(Date:8/19/2014)... is available in German . ... intermittent energy sources. If a large amount of electricity is ... excess energy will have to be stored during productive periods ... storage capacities are far from adequate for the purpose. Science ... important focus lies on battery systems that used to be ...
Breaking Biology News(10 mins):Worker bees 'know' when to invest in their reproductive future 2Biometrics UnPlugged: Mobility at the Crossroads of Commerce & Privacy to Feature Interactive Sessions with Samsung and Experian 2Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
... A*STAR scientists from the Institute of Molecular and Cell Biology ... 100 years, by constructing stable haploid strains of ... This discovery, jointly made by two teams of scientists led ... Berman of the University of Minnesota, will enable scientists to ...
... Chronicle of Higher Education , the National Institutes ... in the review of grant applications. (Found at: ... professor of biomedical engineering at the Virginia ... Engineering and Sciences , and seven of his ...
... the journal Science , today announces the 53 ... Technology Visualization Challenge, a highly competitive contest jointly sponsored ... magazine is published by the American Association for the ... than 200 entries from 18 countries, including entries from ...
Cached Biology News:A*STAR scientists solve century-old mystery by finding stable haploid strains of Candida albicans 2Virginia Tech adjunct and colleagues refute a study on 'racial bias' report in NIH awards 2Virginia Tech adjunct and colleagues refute a study on 'racial bias' report in NIH awards 3Winners of 10th annual International Science & Technology Visualization Challenge announced 2Winners of 10th annual International Science & Technology Visualization Challenge announced 3
(Date:8/20/2014)... 2014 High performance computing (HPC) ... most complete climate and Earth system model to ... issues. , Eight national laboratories, including Lawrence ... Center for Atmospheric Research, four academic institutions and ... participating national laboratories include Argonne, Brookhaven, Lawrence Berkeley, ...
(Date:8/20/2014)... 2014 /PRNewswire-iReach/ -- A case study from Intel ... school,s bioengineering department and the Intel® Internet of ... Academic Program, UCSD,s research focuses on exploring the ... Photo - http://photos.prnewswire.com/prnh/20140819/137540 ... of Dr. Todd P. Coleman , Associate ...
(Date:8/19/2014)... August 19, 2014 Shimadzu Scientific ... systems, Prominence-i and Nexera-i, adding to the company’s ... excellent functionality, an intuitive operating environment, and full ... more efficient workflow for conventional to ultra-high-speed analysis. ... intuitive and intelligent design so users can begin ...
(Date:8/19/2014)... Jolla, CA (PRWEB) August 19, 2014 ... toll Parkinson’s disease can take on an individual. ... extremities, decreased facial expression, problems swallowing and severe depression. ... to the dying off of dopamine producing neurons of ... themselves from a disease that slowly and progressively gets ...
Breaking Biology Technology:New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3
... Vivo Ventures, a venture,capital firm specializing in life ... firm as an Executive in Residence. With his,extensive business ... portfolio companies while enhancing the firm,s presence in,Asia. ... what he will be able to,bring to Vivo," said ...
... Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that ... U.K. Phase Ia/Ib combination,REOLYSIN(R)/radiation clinical trial for ... to be presented today at the AACR-NCI-EORTC,International ... in,San Francisco. The conference runs from October ...
... 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ... letter of approval from the U.K. Medicines ... Clinical Trial Application (CTA) to begin,a clinical ... with cyclophosphamide, a chemotherapeutic agent as well ...
Cached Biology Technology:Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence 2Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide 2Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide 3
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
Request Info...
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
Green Standard is fluorescein....
Biology Products: